Success Stories: EB1B Approval for an Assistant Research Professor in the field of Medical Immunology
On October 23, 2013, we received another EB-1B (Outstanding Researcher or Professor) Approval for an Assistant Research Professor in the field of Medical Immunology (Approval Notice)
General Field: Medical Immunology
Position at the Time of Case Filing: Assistant Research Professor
Petitioner: A private, non-profit organization
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Wisconsin
Approval Notice Date: October 23, 2013
Processing Time: 5 Months
Case Summary:
At North America Immigration Law Group – WeGreened.com, we recently received an EB-1B approval for an assistant research professor in the field of medical immunology. The beneficiary’s outstanding ability, highly skilled background, and impressive record of achievement provided a strong case for his EB1B petition. Specifically, the beneficiary’s research had focused on the advanced study of regulatory B cells, porin, and the Shigella dysenteriae bacteria, all with a strong clinical emphasis. The beneficiary’s research work had resulted in at least 11 peer-reviewed scholarly articles published in leading journals, 1 book chapter, and countless conference abstracts, presentations and proceedings. Furthermore, the beneficiary’s publications had been cited at least 142 times by researchers around the world. In addition, he had been invited to review a grant application for research funding that was submitted by worldwide researchers and scientists. The petitioner in this case was a private, non-profit organization. Our beneficiary’s outstanding expertise is summarized in a quote by an independent recommender: “[The beneficiary] has proven his ability to develop novel ideas and carry out cutting edge scientific investigation. He has achieved success and his research is highly regarded. I trust that his work on immune regulation will continue to break new ground, and I anticipate that his efforts will be directly translatable to the treatment of human autoimmune disease.” It was our goal to prove that this beneficiary qualified for classification as an alien of outstanding professor or researcher given the international recognition for his outstanding achievements. His petition was approved in 5 months.

